Fong Hei Yue Tina 4

What Happened
Fong Hei Yue Tina, Chief Marketing Officer and a director of NewGenIvf Group Ltd (NIVF), was granted an award of 56,851 stock options on 2026-05-04. The Form 4 reports the derivative acquisition (code A); the filing shows $0.00 because it is a grant, but a footnote clarifies the options have an exercise price of US$0.0001 per Class B Ordinary Share. No shares were purchased or sold in this filing — this is an options grant, not an exercise.

Key Details

• Transaction date: May 4, 2026; Form 4 filed May 6, 2026 (timely filing).
• Award: 56,851 stock options to acquire Class B Ordinary Shares.
• Exercise price: US$0.0001 per share (footnote clarification).
• Vesting: 5,685 options vest 4 June 2026; then 1,462 options vest on the 4th of each month from 4 July 2026 through 4 April 2029 (34 monthly tranches); final 1,458 options vest 4 May 2029.
• Expiration: Options expire 4 May 2033, subject to plan/agreements.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing note: Grant made under the issuer’s 2024 Share Incentive Plan and an Employee Stock Option Agreement dated May 4, 2026.

Context
This is a grant of equity compensation (derivative award); it does not involve an immediate cash outlay or sale of shares. The low exercise price (US$0.0001) means future value depends on the company’s stock performance and the vesting schedule; the award vests over multiple tranches through May 2029. As always, an options grant is routine executive compensation and should not be taken alone as a signal of insider sentiment.